Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2025-12-25 @ 11:27 PM
Study NCT ID:
NCT04826393
Status:
COMPLETED
Last Update Posted:
2025-10-22
First Post:
2021-03-30
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
ASP8374 + Cemiplimab in Recurrent Glioma
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-09
Start Date Type:
ACTUAL
Primary Completion Date:
2022-10-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-01
Completion Date Type:
ACTUAL
First Submit Date:
2021-03-30
First Submit QC Date:
None
Study First Post Date:
2021-04-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-20
Last Update Post Date:
2025-10-22
Last Update Post Date Type:
ESTIMATED